{
    "nct_id": "NCT06630117",
    "official_title": "A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Trial to Evaluate the Safety, Tolerability, and Immunogenicity of V330 in Healthy Younger (18 to 49 Years Inclusive) and Healthy Older Participants (60 to 79 Years Inclusive).",
    "inclusion_criteria": "The key inclusion criteria include but are not limited to the following:\n\n* Is in good health prior to randomization\n* Is an individual from 18 to 49 years of age inclusive or from 60 to 79 years of age inclusive\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 79 Years",
    "exclusion_criteria": "The key exclusion criteria include but are not limited to the following:\n\n* Has a history of myocarditis, pericarditis, and/or myopericarditis\n* Has a history of cancer",
    "miscellaneous_criteria": ""
}